Effects of antihypertensives on plasma lipids and lipoprotein metabolism
References (47)
Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties
Am J Med
(1987)- et al.
Effect of chronic administration of propranolol on lipoprotein composition
Metabolism
(1976) - et al.
Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis
Am J Med
(1986) - et al.
Calcium channel blockers stimulate LDL receptor synthesis in human skin fibroblasts
Biochem Biophys Res Comm
(1986) - et al.
Enhancement of cholesteryl ester metabolism in cultured human monocyte-derived macrophages by verapamil
Biochim Biophys Acta
(1985) - et al.
Relation of plasma high density lipoprotein cholesterol to lipoprotein lipase activity in adipose-tissue and skeletal muscle from man
Atherosclerosis
(1978) - et al.
Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoprotein
Metabolism
(1978) High density lipoprotein metabolism
J Lipid Res
(1984)Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial
Am J Med
(1984)- et al.
Stimulation of beta2-adrenergic receptors suppresses sterol synthesis in human mononuclear leukocytes
Biochim Biophys Acta
(1984)
Comparison of in vitro and in vivo effects of prazosin on lipid metabolism
Am J Med
Population studies
Lipid Research Clinics Coronary Primary Prevention Trial results. Reduction in incidence of coronary heart disease
JAMA
Effects of treatment on morbidity in hypertension. 2. Results in patients with diastolic blood pressure averaging 90–114 mm Hg
JAMA
Five-year findings of the hypertension detection and follow up program. 1. Reduction in mortality of persons with high blood pressure including mild hypertension
JAMA
Multiple risk factor intervention trial-risk factor changes and mortality results
JAMA
On the cardiovascular hazards of hypertension
Should mild hypertension be treated?
N Engl J Med
Trials of the treatment of mild hypertension. An interim analysis
Lancet
Antihypertensive Therapie und Fettstoffwechsel
Klin Wochenschr
Effect of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients
Ann Intern Med
Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension
JAMA
Adrenergic mechanisms in control of plasma lipid concentrations
Br Med J
Cited by (97)
Approach to patients with hypertriglyceridemia
2023, Best Practice and Research: Clinical Endocrinology and MetabolismCitation Excerpt :When mild to moderate elevations of triglyceride are secondary to the use of drugs, alternate medications should be substituted when possible. This is particularly important in the management of hypertension, where diuretics and beta-adrenergic blocking agents should be replaced by lipid-neutral agents such as calcium channel blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or alpha-adrenergic blocking agents, the latter of which can even reduce triglyceride levels slightly [69]. Transdermal estrogens have less of an effect on plasma triglycerides than oral estrogens.
Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?
2021, Revista Espanola de CardiologiaTriglyceride Treatment in the Age of Cholesterol Reduction
2016, Progress in Cardiovascular DiseasesCitation Excerpt :Cardioselective beta-blocker monotherapy usually increases serum TGs and decreases the concentration of HDL, especially HDL2 cholesterol.65 This is likely a drug class-related effect, since non-specific beta-blockers with intrinsic sympathomimetic activity, such as oxprenolol and pindolol, appear to produce qualitatively similar but less pronounced changes in circulating lipids.66 In combination, a tendency for increased TG and lower HDL was also apparent during thiazide-type diuretic-beta-blocker therapy.67
Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?
2010, Pharmacological ReportsCitation Excerpt :It is possible that such a high dose of nebivolol in our model caused loss of receptor selectivity. Non-selective P-blockers may induce an increase in TG levels [17]. We could not exclude the possibility that LPS influenced the lipid profile.
A Comprehensive Update on the Chylomicronemia Syndrome
2020, Frontiers in Endocrinology